| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2821434 | F | 01/17/2025 |
UNK |
UNKNOWN MANUFACTURER |
No batch number |
Influenza
Influenza
|
Patient recently became infected with influenza virus following seasonal influenza vaccination; This...
Patient recently became infected with influenza virus following seasonal influenza vaccination; This spontaneous case, initially received on 07-Jan-2025, was reported by a health professional and concerns an Other female patient. Patient's medical history and concomitant Medications were unknown. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for Active immunization against influenza disease. Dose regimen: Not reported, Route of Administration: Not reported, Anatomical location: Not reported, Lot number: No batch number available, and will be requested upon follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the Patient recently became infected with influenza virus following seasonal influenza vaccination (Medically significant, outcome: Unknown). It was reported that, the patient recently became infected with influenza virus following seasonal influenza vaccination. Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The reporter did not provide seriousness and causality assessment. The event influenza upgraded to serious considering event's clinical significance; Reporter's Comments: Due to the spontaneous nature of the case, it is considered related for reporting purposes. Causal association could not be completely ruled out in view of insufficient information, hence causality assessed as related.
More
|
||||||||
| 2821443 | 33 | F | CO | 01/17/2025 |
RSV RSV |
PFIZER\WYETH PFIZER\WYETH |
|
Abdominal pain upper, Chills, Delivery, Exposure during pregnancy, Pre-eclampsia...
Abdominal pain upper, Chills, Delivery, Exposure during pregnancy, Pre-eclampsia; Pyrexia
More
|
Fever of 101.5 started 12 hours after receiving vaccine and lasted another 12 hours, had chills, sto...
Fever of 101.5 started 12 hours after receiving vaccine and lasted another 12 hours, had chills, stomachache. I was 36 weeks pregnant (2nd pregnancy) with an estimated due date of 7/14/24. I delivered at 38 weeks due to sudden onset of preeclampsia on 7/X/24 - healthy baby at 7 lbs 4 oz.
More
|
||||||
| 2821446 | 52 | M | 01/17/2025 |
COVID19 COVID19 UNK UNK |
UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SAR...
Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SARS-CoV-2 test; Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SARS-CoV-2 test
More
|
malaise; psittacosis; Initial information received on 13-Jan-2025 regarding an unsolicited valid non...
malaise; psittacosis; Initial information received on 13-Jan-2025 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 52 years old male patient who experienced malaise and psittacosis after receiving Influenza trivalent recombinant vaccine [Flublok TIV] and Novavax covid-19 vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Citalopram (Citalopram) and Valaciclovir hydrochloride (Valtrex) for Product used for unknown indication. On 15-Nov-2024, the patient received a dose 1 of suspect influenza trivalent recombinant vaccine lot number Solution for injection not reported via intramuscular route in unknown administration site for prophylactic immunization and received a dose 1 of suspect Novavax covid-19 vaccine not produced by Sanofi Pasteur lot number not reported via intramuscular route in unknown administration site (frequency, route, strength and expiration date: not provided) for prophylactic immunization. Information regarding batch number and expiration date corresponding to the one at a time of event occurrence was requested. On 22-NOV-2024 the patient developed malaise and psittacosis (latency- 7 days). Relevant laboratory test results included: Culture stool - On an unknown date: [unknown] Full blood count - On an unknown date: [unknown] Influenza virus test - On an unknown date: [unknown] SARS-CoV-2 test - On an unknown date: [unknown] Action taken- not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Recovered / Resolved on an unknown date for both the events.
More
|
|||||||
| 2821447 | 0.5 | M | CO | 01/17/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
UK044AA |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
pentacel diluent was administered prior to reconstitution with no reported adverse event; Initial in...
pentacel diluent was administered prior to reconstitution with no reported adverse event; Initial information received on 09-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6-month-old male patient whom diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] diluent was administered prior to reconstitution with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included rotavirus vaccine live reassort oral 5V (Rotateq); and pneumococcal vaccine conj 15V (CRM197) (Vaxneuvance) for Immunisation. On 09-Jan-2024, a 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection of lot UK044AA and expiry date: 31-Aug-2025 strength: standard frequency: once via intramuscular route in the left thigh for immunization diluent was administered prior to reconstitution with no reported adverse event (wrong technique in product usage process) (latency: on same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
More
|
||||||
| 2821448 | F | SD | 01/17/2025 |
FLU3 |
SANOFI PASTEUR |
UT481AB |
COVID-19, Dyspnoea
COVID-19, Dyspnoea
|
covid; shortness of breath; Initial information received on 09-Jan-2025 regarding an unsolicited val...
covid; shortness of breath; Initial information received on 09-Jan-2025 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional. This case involves an unknown age female patient who experienced covid and shortness of breath after receiving Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone]. The patient's past medical history, medical treatment(s), vaccination(s),concomitant medications and family history were not provided. On an unknown date, the patient received a unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine (Suspension for injection) lot UT481AB via unknown route in unknown administration site for Prophylactic vaccination (immunization) (strength, expiry date was unknown). On an unknown date the patient developed covid (covid-19) and shortness of breath (dyspnoea) (unknown latency) following the administration of Influenza Usp Trival A-B Subvirion No Preservative Vaccine. Reportedly "Caller wanted to know the ingredients of the vaccine that was injected to their sister on 2011 for them to avoid to see if there are other vaccines that could be given to the patient. " Action taken was not applicable for all the events. It was not reported if the patient received a corrective treatment for the events (shortness of breath, covid). At time of reporting, the outcome was Unknown for the events shortness of breath and covid.
More
|
|||||||
| 2821450 | 24 | M | TX | 01/17/2025 |
HEP IPV VARCEL |
DYNAVAX TECHNOLOGIES CORPORATION SANOFI PASTEUR MERCK & CO. INC. |
945655 W1C741M Y006523 |
Syncope; Syncope; Syncope
Syncope; Syncope; Syncope
|
Patient fainted after receiving vaccines.
Patient fainted after receiving vaccines.
|
||||||
| 2821451 | 21 | F | FL | 01/17/2025 |
COVID19 IPV MMR VARCEL |
PFIZER\BIONTECH SANOFI PASTEUR MERCK & CO. INC. MERCK & CO. INC. |
LP1780 X1C891M X027903 Y013347 |
Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function ...
Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis
More
|
Weakness, paralysis of left side of her face. Unable to close left eye.
Weakness, paralysis of left side of her face. Unable to close left eye.
|
โ | |||||
| 2821452 | 1 | F | CO | 01/17/2025 |
HEPA HIBV MNQ PNC20 |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. NOVARTIS VACCINES AND DIAGNOSTICS PFIZER\WYETH |
BM4R5 Y005248 X4T99 LCC5483 |
Product administered to patient of inappropriate age; Product administered to pa...
Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age
More
|
Patient was accidentally given the Menvo MCV4 vaccination intended for patients over the age of 10. ...
Patient was accidentally given the Menvo MCV4 vaccination intended for patients over the age of 10. Patient is a 1-year-old. We spoke with the manufacturer and have attached the information that htey sent to us this morning. After discussing with the provider, she felt that there should not be any major side effects since there are exceptions that the vaccine can be given at a younger age. Provider has reached out to mother of child x2 with no response.
More
|
||||||
| 2821499 | 1 | F | NC | 01/17/2025 |
MMRV |
MERCK & CO. INC. |
Y013580 |
Extra dose administered, Wrong product administered
Extra dose administered, Wrong product administered
|
Nurse was attempting to give 1 year old vaccines MMR and Varicella. Nurse mistakenly grabbed ProQuad...
Nurse was attempting to give 1 year old vaccines MMR and Varicella. Nurse mistakenly grabbed ProQuad and Varicella resulting in the patient receiving a double dose of Varicella.
More
|
||||||
| 2821500 | 63 | F | PR | 01/17/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
74nc9 |
Discomfort, Limb discomfort, Mobility decreased, Painful respiration, Spinal pai...
Discomfort, Limb discomfort, Mobility decreased, Painful respiration, Spinal pain
More
|
Patient, as the days went by, the effects worsened. On the first day I experienced general discomfor...
Patient, as the days went by, the effects worsened. On the first day I experienced general discomfort. On the second day there was a lot of discomfort in the arm but on the third day the patient stated that she could not move, pain in the spine that prevented her mobility and when breathing she also experienced pain in the spine. she feels like she's paralyzed
More
|
||||||
| 2821501 | 59 | F | NY | 01/17/2025 |
COVID19 |
PFIZER\BIONTECH |
LM2216 |
Erythema, Pruritus
Erythema, Pruritus
|
Patient developed redness and itching
Patient developed redness and itching
|
||||||
| 2821502 | 1 | M | DC | 01/17/2025 |
FLU3 |
SANOFI PASTEUR |
|
Product lot number issue
Product lot number issue
|
PCV20 lot # was used in documentation for both the PCV20 and flu vaccine order. Unable to confirm i...
PCV20 lot # was used in documentation for both the PCV20 and flu vaccine order. Unable to confirm if pt did received first flu dose. Pt advised to repeat influenza vaccination.
More
|
||||||
| 2821503 | 17 | M | PA | 01/17/2025 |
MMR |
MERCK & CO. INC. |
X002058 |
No adverse event
No adverse event
|
NO SIGNS OR SYMPTOMS OF ADVERSE. VACCINE WAS GIVEN IM VERSES SUBCUTANOUS. DOCTOR NOTIFIED AND THIS ...
NO SIGNS OR SYMPTOMS OF ADVERSE. VACCINE WAS GIVEN IM VERSES SUBCUTANOUS. DOCTOR NOTIFIED AND THIS DOSE COUNTS. NO FURTHER ACTION NEEDED
More
|
||||||
| 2821504 | 0.08 | M | DC | 01/17/2025 |
DTPPVHBHPB PNC20 RV1 |
MSP VACCINE COMPANY PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
U7921AA LC5484 5N2AN |
Incorrect dose administered; Incorrect dose administered; Incorrect dose adminis...
Incorrect dose administered; Incorrect dose administered; Incorrect dose administered
More
|
Pt ordered to received 50mg dose of Beyfortus based on weight. Pt was given 100mg dose based on lot ...
Pt ordered to received 50mg dose of Beyfortus based on weight. Pt was given 100mg dose based on lot number used in vaccine documentation.
More
|
||||||
| 2821505 | 1.17 | M | MI | 01/17/2025 |
HIBV |
SANOFI PASTEUR |
|
Product preparation error
Product preparation error
|
HIB powder was mixed with a standard diluent instead of the diluent that is provided with vaccine.
HIB powder was mixed with a standard diluent instead of the diluent that is provided with vaccine.
|
||||||
| 2821506 | 30 | M | DC | 01/17/2025 |
HPV9 TDAP |
MERCK & CO. INC. SANOFI PASTEUR |
Y013469 LC5482 |
Extra dose administered, Product lot number issue; Extra dose administered, Prod...
Extra dose administered, Product lot number issue; Extra dose administered, Product lot number issue
More
|
PCV20 lot # used for documentation of tdap vaccine. Unable to determine if pt received tdap vaccine...
PCV20 lot # used for documentation of tdap vaccine. Unable to determine if pt received tdap vaccine. Additionally, pt received PCV vaccine on 12/30/24, so pt received 2 doses of PCV.
More
|
||||||
| 2821507 | 71 | M | TX | 01/17/2025 |
FLU3 |
SANOFI PASTEUR |
u8532ca |
Deafness unilateral, Sudden hearing loss
Deafness unilateral, Sudden hearing loss
|
I received the flu vaccine on the afternoon of 01/10/2025. In the early morning hours of 01/13/2025 ...
I received the flu vaccine on the afternoon of 01/10/2025. In the early morning hours of 01/13/2025 I suddenly lost hearing in my left ear. The hearing loss lasted about 16 hours. Later during the evening of 01/13/2025 my hearing gradually returned. I haven't noticed any residual effects since.
More
|
||||||
| 2821508 | 2 | F | WI | 01/17/2025 |
COVID19 |
MODERNA |
3044186 |
Expired product administered
Expired product administered
|
Patient received expired COVID vaccine. Vaccine has 60 life in fridge, given at 61 days.
Patient received expired COVID vaccine. Vaccine has 60 life in fridge, given at 61 days.
|
||||||
| 2821509 | 66 | M | WV | 01/17/2025 |
COVID19 |
MODERNA |
3043823 |
Chest X-ray normal, Dyspnoea, Rash
Chest X-ray normal, Dyspnoea, Rash
|
Rash to abdomen that resolved with Hydrocortisone cream, Mild Shortness of breath -
Rash to abdomen that resolved with Hydrocortisone cream, Mild Shortness of breath -
|
||||||
| 2821510 | 39 | M | NJ | 01/17/2025 |
COVID19 COVID19 |
MODERNA MODERNA |
014c21a 014c21a |
Abdominal pain upper, Colitis ulcerative, Diarrhoea, Haematochezia, Immediate po...
Abdominal pain upper, Colitis ulcerative, Diarrhoea, Haematochezia, Immediate post-injection reaction; Influenza like illness, Malaise
More
|
I became very sick, flu like symptoms immediately after receiving shot. This included stomach pains ...
I became very sick, flu like symptoms immediately after receiving shot. This included stomach pains and diarrhea. Stomach issues never went away and within a few days I began to see blood in my stool for the first time in my life. I've since been diagnosed with ulcerative colitis and being treated with remicaid.
More
|
||||||
| 2821511 | 26 | F | MA | 01/17/2025 |
VARCEL |
MERCK & CO. INC. |
|
Expired product administered
Expired product administered
|
Patient was given vaccine that expired 1 day ago. Vaccine was administered on 1/10/25. Vaccine expir...
Patient was given vaccine that expired 1 day ago. Vaccine was administered on 1/10/25. Vaccine expired on 1/9/25.
More
|
||||||
| 2821512 | 56 | F | WI | 01/17/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96867 |
Influenza like illness, Injection site erythema, Injection site induration, Inje...
Influenza like illness, Injection site erythema, Injection site induration, Injection site pruritus
More
|
Pt was due for her 2 year booster. Pt did note on initial series (11/21/2022 & 12/20/22) signi...
Pt was due for her 2 year booster. Pt did note on initial series (11/21/2022 & 12/20/22) significant vesicle development, induration and itching. VAERS was submitted (VAERS E-report 918671 submitted on 12/01/22). Patient is a Vet Pathologist who works with mpox in research lab. Pt was due for booster. Given patient Occupational Exposure risk, risk vs benefit of booster vaccination was discussed with patient including discussion if unknown if same/worsening side effects could occur again. (serum testing for immunity not available at this time) Patient decided to proceed with Jynneos booster. Booster given on 12/20/24. Pt notes side effects were significant. Photos submitted notes reddness from injection site 10 cm long with induration. Pt notes "flu like " symptoms from 12/21 to 12/23. Pt had tissue reaction fairly significant by 12/22 -12/23 (day 2 and 3). Pt notes she managed symptoms with NSAIDS and benadryl. Pt notes she took regular doses of Benadryl for 10 days to control symptoms of very intense itching at injection site . As of 1/3/25 nodular reaction was size of lima bean
More
|
||||||
| 2821513 | 1 | F | MN | 01/17/2025 |
DTPPVHBHPB DTPPVHBHPB DTPPVHBHPB FLU3 FLU3 FLU3 MMR MMR MMR UNK UNK UNK |
MSP VACCINE COMPANY MSP VACCINE COMPANY MSP VACCINE COMPANY GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. MERCK & CO. INC. UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER UNKNOWN MANUFACTURER |
|
Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petech...
Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal
More
|
Developed thrombocytopenia 2 weeks following vaccine administration. Has mucosal purpura, limb brui...
Developed thrombocytopenia 2 weeks following vaccine administration. Has mucosal purpura, limb bruising, petechiae.
More
|
โ | |||||
| 2821514 | 57 | F | MN | 01/17/2025 |
PNC20 |
PFIZER\WYETH |
LG5577 |
Injection site pain, Pain, Paraesthesia
Injection site pain, Pain, Paraesthesia
|
moderate/severe pain at/around site. Patient reported tingling that radiated down her left arm for a...
moderate/severe pain at/around site. Patient reported tingling that radiated down her left arm for a couple days. Pain described as sharp/burning. Since improved.
More
|
||||||
| 2821515 | 0.58 | F | MD | 01/17/2025 |
COVID19 |
PFIZER\BIONTECH |
LN8272 |
No adverse event, Product preparation issue
No adverse event, Product preparation issue
|
About 1.5hrs after administration of vaccine, vial was noted to only have enough liquid for one addi...
About 1.5hrs after administration of vaccine, vial was noted to only have enough liquid for one additional COVID dose remaining (though it should have had 2 doses remaining in vial). Suspect that inadequate diluent was added to reconstitute the vaccine, resulting in administration of a more concentrated dose (unknown how concentrated) to the patient. Patient did not demonstrate any side effects.
More
|
||||||
| 2821517 | 61 | F | MO | 01/17/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
4H79Y 4H79Y |
Chills, Erythema, Injection site reaction, Pain, Pain in extremity; Skin warm, U...
Chills, Erythema, Injection site reaction, Pain, Pain in extremity; Skin warm, Urticaria
More
|
On the following day at around 7:30 AM on Wednesday January 15th client developed a whelp the size o...
On the following day at around 7:30 AM on Wednesday January 15th client developed a whelp the size of a tennis ball at injection site and then had a 3 raised areas several inches below injection site that were the size of half dollars. Her arm was very warm to touch and sore. Client also noticed left backside of shoulder had redness and warmth. Client left cheek also was reddened in appearance. She also experienced severe body chills and body aches.
More
|
||||||
| 2821518 | 57 | F | PR | 01/17/2025 |
COVID19 FLU3 VARZOS |
PFIZER\BIONTECH GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
LM2219 KM5GK 94SE2 |
Peripheral swelling; Peripheral swelling; Peripheral swelling
Peripheral swelling; Peripheral swelling; Peripheral swelling
|
HER RIGTH ARM WAS A LITTLE SWOLLEN, THE DAY BEFORE , ACCORDING TO THE PATIENT WAS MORE SWOLLEN AND ...
HER RIGTH ARM WAS A LITTLE SWOLLEN, THE DAY BEFORE , ACCORDING TO THE PATIENT WAS MORE SWOLLEN AND HAD BEGUN TO GO DOWN
More
|
||||||
| 2821519 | 76 | F | FL | 01/17/2025 |
RSV |
PFIZER\WYETH |
|
Pain in extremity
Pain in extremity
|
Thigh and leg pain. Pain in the front and back of thigh on the mostly the right side. Some pain on...
Thigh and leg pain. Pain in the front and back of thigh on the mostly the right side. Some pain on front thigh left side.
More
|
||||||
| 2821521 | 45 | F | MD | 01/17/2025 |
COVID19 |
PFIZER\BIONTECH |
EW0217 |
Idiopathic angioedema, Lip swelling, Ophthalmic migraine, Swelling, Swelling fac...
Idiopathic angioedema, Lip swelling, Ophthalmic migraine, Swelling, Swelling face
More
|
Significant swelling of lip and face, visual migraine. The swelling has occurred repeatedly afterwa...
Significant swelling of lip and face, visual migraine. The swelling has occurred repeatedly afterwards. At first, the severe facial swelling happened every few months, but then increased in frequency and began occurring on other parts of the body, as well. Swelling happened multiple times per week. Was diagnosed as "idiopathic angioedema" one year ago and is controlled with daily allergy medication. Swelling returns when medication is not taken.
More
|
||||||
| 2821522 | 3 | M | MN | 01/17/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
EK7DG |
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
Patient received single vial presentation rather than 2-vial presentation of Menveo. No signs or sym...
Patient received single vial presentation rather than 2-vial presentation of Menveo. No signs or symptoms of adverse event.
More
|
||||||
| 2821523 | 62 | M | WA | 01/17/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Chills, Cold sweat, Injection site pain, Insomnia, Pyrexia
Chills, Cold sweat, Injection site pain, Insomnia, Pyrexia
|
fever, cold sweats, chills difficulty sleeping lasting 36 hours. injection site soreness lasting 48...
fever, cold sweats, chills difficulty sleeping lasting 36 hours. injection site soreness lasting 48 hours.
More
|
||||||
| 2821524 | 6 | M | MI | 01/17/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
Immunization was incorrectly given as a first dose of DTaP and first dose of IPV.
Immunization was incorrectly given as a first dose of DTaP and first dose of IPV.
|
||||||
| 2821525 | 9 | M | MN | 01/17/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
J44K5 |
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
Patient received single vial presentation instead of 2-vial presentation. No adverse events noted.
Patient received single vial presentation instead of 2-vial presentation. No adverse events noted.
|
||||||
| 2821526 | 5 | M | MI | 01/17/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Inappropriate schedule of product administration
Inappropriate schedule of product administration
|
The DTaP/IPV vaccine was incorrectly given to a patient as their first dose of DTaP and first dose o...
The DTaP/IPV vaccine was incorrectly given to a patient as their first dose of DTaP and first dose of IPV.
More
|
||||||
| 2821527 | 55 | F | MA | 01/17/2025 |
VARZOS VARZOS VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
g79dh g79dh |
Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product admi...
Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product administered at inappropriate site; Joint injury; Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product administered at inappropriate site; Joint injury
More
|
Administration was very high/superior, did not follow proper landmarks for deltoid administration, c...
Administration was very high/superior, did not follow proper landmarks for deltoid administration, caused immediate extraordinary pain soon followed by impaired shoulder mobility (frozen shoulder for several days improved, but sharp pain with particular movements has persisted even now, months later), appears to have entered joint capsule rather than IM into deltoid, unknown at this time if injury/damage is permanent
More
|
||||||
| 2821528 | 17 | F | MI | 01/17/2025 |
MMRV |
MERCK & CO. INC. |
|
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
MMRV was incorrectly given to this patient at the age of 17 years
MMRV was incorrectly given to this patient at the age of 17 years
|
||||||
| 2821529 | 93 | F | GA | 01/17/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
52z52 |
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Patient got a second dose of Arexvy after getting a dose on 12/16/23, Spoke with her on 1/17/25. She...
Patient got a second dose of Arexvy after getting a dose on 12/16/23, Spoke with her on 1/17/25. She did not have any side effects that she was aware of since vaccination.
More
|
||||||
| 2821530 | 9 | F | MI | 01/17/2025 |
DTAP |
GLAXOSMITHKLINE BIOLOGICALS |
|
Product administered to patient of inappropriate age
Product administered to patient of inappropriate age
|
The patient received a DTaP vaccine in error, as based on their age they should have received the Td...
The patient received a DTaP vaccine in error, as based on their age they should have received the Tdap vaccine.
More
|
||||||
| 2821531 | 23 | F | FL | 01/17/2025 |
YF |
SANOFI PASTEUR |
UK118AA |
Dizziness, Loss of consciousness, Presyncope
Dizziness, Loss of consciousness, Presyncope
|
After leaving the immunization room and upon returning to the observation area the patient got light...
After leaving the immunization room and upon returning to the observation area the patient got light headed and passed out exhibiting signs of a vasovagal reaction to the vaccine. The patient came to almost immediately asking what occurred. The patient had a friend with her. I spent some time with the patient. She was given water to sip on and stayed with us about 30 minutes longer. She stated she was feeling fine upon leaving.
More
|
||||||
| 2821532 | 86 | F | AR | 01/17/2025 |
COVID19 |
MODERNA |
016B21A |
COVID-19
COVID-19
|
hospitalization with covid infection after vaccination
hospitalization with covid infection after vaccination
|
||||||
| 2821533 | 1 | M | IL | 01/17/2025 |
COVID19 |
PFIZER\BIONTECH |
LN6739 |
No adverse event
No adverse event
|
Nos symptoms at this time
Nos symptoms at this time
|
||||||
| 2821534 | 72 | F | AR | 01/17/2025 |
COVID19 |
MODERNA |
049L21A |
COVID-19
COVID-19
|
hospitalization for covid infection after vaccination
hospitalization for covid infection after vaccination
|
||||||
| 2821536 | 87 | M | AR | 01/17/2025 |
COVID19 |
MODERNA |
019H22A |
COVID-19
COVID-19
|
hospitalization for covid infection after vaccination
hospitalization for covid infection after vaccination
|
||||||
| 2821537 | 2 | F | IL | 01/17/2025 |
COVID19 FLU3 |
PFIZER\BIONTECH SANOFI PASTEUR |
LN8272 UT84O8NA |
No adverse event; No adverse event
No adverse event; No adverse event
|
No symptoms at this time
No symptoms at this time
|
||||||
| 2821538 | 13 | F | VA | 01/17/2025 |
FLU3 |
SANOFI PASTEUR |
|
Extra dose administered, No adverse event
Extra dose administered, No adverse event
|
Pt received second fluzone trivalent vaccine for 24-25 season. Pt had no adverse reactions, immediat...
Pt received second fluzone trivalent vaccine for 24-25 season. Pt had no adverse reactions, immediately after injection nor any adverse symptoms reported by parents in the days after administration.
More
|
||||||
| 2821539 | 81 | M | AR | 01/17/2025 |
COVID19 |
MODERNA |
3043823 |
COVID-19
COVID-19
|
hospitalization for covid infection after vaccination
hospitalization for covid infection after vaccination
|
||||||
| 2821540 | 53 | F | 01/17/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Laboratory test normal, Neurological symptom
Laboratory test normal, Neurological symptom
|
Chronic neurologic symptoms with normal neurology evaluation and laboratory testing
Chronic neurologic symptoms with normal neurology evaluation and laboratory testing
|
|||||||
| 2821541 | 82 | F | FL | 01/17/2025 |
FLU3 TDAP VARZOS |
SEQIRUS, INC. GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
388482 3bh5k 334t3 |
Rash; Rash; Rash
Rash; Rash; Rash
|
Patient presents on 1/17/25, complaining of a sporadic rash on her arms. Upon RPh observation, absen...
Patient presents on 1/17/25, complaining of a sporadic rash on her arms. Upon RPh observation, absence of reaction at injection site was noted, however patient does appear to have a handful of blemishes on her forearms bilaterally and one blemish underneath the left armpit. Patient was advised to address concern with her PCP, however she declined. Pharmacist then recommended to the patient to apply a mix of Benadryl and Hydrocortisone cream bid for 5 days, and if no improvement in symptoms, to seek medical care. Patient demonstrated understanding.
More
|
||||||
| 2821543 | 59 | M | AR | 01/17/2025 |
COVID19 |
MODERNA |
068H21A |
COVID-19
COVID-19
|
hospitalization for covid infection after vaccination
hospitalization for covid infection after vaccination
|
||||||
| 2821544 | 85 | M | AR | 01/17/2025 |
COVID19 |
MODERNA |
3030366 |
COVID-19
COVID-19
|
hospitalization for covid infection after vaccination
hospitalization for covid infection after vaccination
|